Research Paper Volume 13, Issue 20 pp 23810—23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Figure 3. Comparison of mutation (A) and CNV (B) landscapes between CCR5 high expression and low expression groups.